Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 5, 2008 - Issue 5
Submit an article Journal homepage
731
Views
92
CrossRef citations to date
0
Altmetric
Review

Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles

Guilin Wang Faculty of Engineering University of Alberta, Department of Chemical & Materials Engineering, #526 CME Building, Edmonton, Alberta, T6G2G6, Canada
&
Hasan Uludag Faculty of Medicine University of Alberta, Department of Biomedical Engineering, Edmonton, Alberta, T6G2G6, Canada; Faculty of Pharmacy and Pharmaceutical Sciences University of Alberta, Edmonton, Alberta, T6G2G6, Canada +1 780 492 0988; +1 780 492 2881; [email protected]
Pages 499-515 | Published online: 20 May 2008

Bibliography

  • Socinski M. Update on nanoparticle albumin-bound paclitaxel. Clin Adv Hematol Oncol 2006;4:745-6
  • Mehnert W, Mader K. Solid lipid nanoparticles Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96
  • Muller BG, Leuenberger H, Kissel T. Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm Res 1996;13:32-7
  • Raghuvanshi RS, Goyal S, Singh O, Panda AK. Stabilization of dichloromethane-induced protein denaturation during microencapsulation. Pharm Dev Technol 1998;3:269-76
  • Sturesson C, Carlfors J. Incorporation of protein in PLG-microspheres with retention of bioactivity. J Control Rel 2000;67:171-8
  • Chawla JS, Amiji MM. Biodegradable poly(ϵ-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127-38
  • Nehilla BJ, Bergkvist M, Popat KC, Desai TA. Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. Int J Pharm 2007;348:107-14
  • Sussman EM, Clarke MB Jr, Shastri VP. Single-step process to produce surface-functionalized polymeric nanoparticles. Langmuir 2007;23:12275-9
  • Zambaux MF, Bonneaux F, Gref R, et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Rel 1998;50:31-40
  • Song X, Zhao Y, Wu W, et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm 2008;350:320-9
  • Tewes F, Munnier E, Antoon B, et al. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm 2007;66:488-92
  • Li YP, Pei YY, Zhang XY, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Rel 2001;71:203-11
  • Garinot M, Fiévez V, Pourcelle V, et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Rel 2007;120:195-204
  • Mishra V, Mahor S, Rawat A, et al. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target 2006;14:45-53
  • Chung YI, Ahn KM, Jeon SH, et al. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Rel 2007;121:91-9
  • Isobe M, Yamazaki Y, Mori M, et al. The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat. J Biomed Mater Res 1999;45:36-41
  • Meinel L, Zoidis E, Zapf J, et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 2003;33:660-72
  • Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 2000;194:91-102
  • Lin W, Coombes AGA, Davies MC, et al. Preparation of sub-100 nm human serum albumin nanoparticles using a pH-coacervation method. J Drug Target 1993;1:237-43
  • Langer K, Balthasar S, Vogel V, et al. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 2003;257:169-80
  • Ko S, Gunasekaran S. Preparation of sub-100-nm β-lactoglobulin (BLG) nanoparticles. J Microencapsul 2006;23:887-98.:
  • Lin W, Garnett MC, Schacht E, et al. Preparation and in vitro characterization of HSA-mPEG nanoparticles. Int J Pharm 1999;189:161-70
  • Segura S, Gamazo C, Irache JM, Espuelas S. Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus. Antimicrob Agents Chemother 2007;51:1310-4
  • Zhang S, Wang G, Lin X, et al. Polyethylenimine-coated albumin nanopartices for BMP-2 delivery. Biotechnol Prog 2007; accepted
  • Merodio M, Arnedo A, Renedo MJ, Irache JM. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur J Pharm Sci 2001;12:251-9
  • Segura S, Espuelas S, Renedo MaJs, Irache JM. Potential of albumin nanoparticles as carriers for interferon-gamma. Drug Dev Ind Pharm 2005;31:271-80
  • Leo E, Vandelli MA, Cameroni R, Forni F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int J Pharm 1997;155:75-82
  • Willmott N, Cummings J, Florence AT. in vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres. J Microencapsul 1985;2:293-304
  • Dreis S, Rothweiler F, Michaelis M, et al. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm 2007;341:207-14
  • Arnedo A, Irache JM, Merodio M, Espuelas Millan MS. Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide. J Control Rel 2004;94:217-27
  • Chen CQ, Lin W, Coombes AGA, et al. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method. J Microencapsul 1994;11:395-407
  • Lin W, Coombes AGA, Garnett MC, et al. Preparation of sterically stabilized human serum albumin nanospheres using a novel dextranox-MPEG crosslinking agent. Pharm Res 1994;11:1588-92
  • Wang Y, Gao JY, Dubin PL. Protein separation via polyelectrolyte coacervation: selectivity and efficiency. Biotechnol Prog 1996;12:356-62
  • Farrell LL, Pepin J, Kucharski C, et al. A comparison of the effectiveness of cationic polymers poly-l-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). Eur J Pharm Biopharm 2007;65:388-97
  • Nisha CK, Manorama SV, Ganguli M, et al. Complexes of poly(ethylene glycol)-based cationic random copolymer and calf thymus DNA: a complete biophysical characterization. Langmuir 2004;20:2386-96
  • Dautzenberg H, Zintchenko A, Konak C, et al. Polycationic graft copolymers as carriers for oligonucleotide delivery: complexes of oligonucleotides with polycationic graft copolymers. Langmuir 2001;17:3096-102
  • Serefoglou E, Oberdisse J, Staikos G. Characterization of the soluble nanoparticles formed through coulombic interaction of bovine serum albumin with anionic graft copolymers at low pH. Biomacromolecules 2007;8:1195-9
  • Matsudo T, Ogawa K, Kokufuta E. Complex formation of protein with different water-soluble synthetic polymers. Biomacromolecules 2003;4:1794-9
  • Rhaese S, von Briesen H, Rubsamen-Waigmann H, et al. Human serum albumin- polyethylenimine nanoparticles for gene delivery. J Control Rel 2003;92:199-208
  • Vogel V, Lochmann D, Weyermann J, et al. Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. J Control Release 2005;103:99-111
  • Balabushevitch NG, Sukhorukov GB, Moroz NA, et al. Encapsulation of proteins by layer-by-layer adsorption of polyelectrolytes onto protein aggregates: factors regulating the protein release. Biotechnol Bioeng 2001;76:207-13
  • Fan YF, Wang YN, Fan YG, Ma JB. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int J Pharm 2006;324:158-67
  • Amidi M, Romeijn SG, Borchard G, et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 2006;111:107-16
  • Xu Y, Du Y, Huang R, Gao L. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 2003;24:5015-22
  • Malafaya PB, Silva GA, Baran ET, Reis RL. Drug delivery therapies I: general trends and its importance on bone tissue engineering applications. Curr Opin Solid State Mater Sci 2002;6:283-95
  • Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20
  • Lee KY, Yuk SH. Polymeric protein delivery systems. Prog Polym Sci 2007;32:669-97
  • Stolnik S, Dunn SE, Garnett MC, et al. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly (ethylene glycol) copolymers. Pharm Res 1994;11:1800-8
  • Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science 1994;263:1600-3
  • Townsend SA, Evrony GD, Gu FX, et al. Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons. Biomaterials 2007;28:5176-84
  • Gryparis EC, Mattheolabakis G, Bikiaris D, Avgoustakis K. Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin. Drug Deliv 2007;14:371-80
  • Gref R, Luck M, Quellec P, et al. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000;18:301-13
  • Bergstrom K, Osterberg E, Holmberg K, et al. Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection. J Biomater Sci Polym Ed 1994;6:123-32
  • Choi SW, Kim JH. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007;122:24-30
  • Kenausis GL, Voros J, Elbert DL, et al. Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: attachment mechanism and effects of polymer architecture on resistance to protein adsorption. J Phys Chem B 2000;104:3298-309
  • Huang NP, Michel R, Voros J, et al. Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: surface-analytical characterization and resistance to serum and fibrinogen adsorption. Langmuir 2001;17:489-98
  • VandeVondele S, Voros J, Hubbell JA. RGD-grafted poly-l-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng 2003;82:784-90
  • Faraasen S, Voros J, Csucs G, et al. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res 2003;20:237-46
  • Lin W, Garnett MC, Davies MC, et al. Preparation of surface-modified albumin nanospheres. Biomaterials 1997;18:559-65
  • Moghimi SM, Hedeman H, Muir IS, et al. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta 1993;1157:233-40
  • Harashima H, Sakata K, Funato K, Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm Res 1994;11:402-6
  • Porter CJH, Moghimi SM, Illum L, Davis SS. The polyoxyethylene/polyoxypropylene block co-polymer Poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992;305:62-6
  • Hirabayashi H, Fujisaki J. Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents. Clin Pharmacokinet 2003;42:1319-30
  • Wang D, Miller S, Sima M, et al. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems. Bioconjugate Chem 2003;14:853-9
  • Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283-318
  • van Rooijen N, van Kesteren-Hendrikx E. Clodronate liposomes: perspectives in research and therapeutics. J Liposome Res 2002;12:81-94
  • Li P, Tan Z, Zhu Y, et al. Targeting study of gelatin adsorbed clodronate in reticuloendothelial system and its potential application in immune thrombocytopenic purpura of rat model. J Control Release 2006;114:202-8
  • Owens DE III, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93-102
  • Roser M, Fischer D, Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 1998;46:255-63
  • Bertholon I, Vauthier C, Labarre D. Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 2006;23:1313-23
  • Fang C, Shi B, Pei Y-Y, et al. in vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 2006;27:27-36
  • Zahr AS, Davis CA, Pishko MV. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 2006;22:8178-85
  • Zambaux MF, Bonneaux F, Gref R, et al. Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles. Int J Pharm 2001;212:1-9
  • Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Rel 2007;119:77-85
  • Zambaux MF, Bonneaux F, Gref R, et al. Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Rel 1999;60:179-88
  • Sun B, Ranganathan B, Feng SS. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008;29:475-86
  • Wartlick H, Spankuch-Schmitt B, Strebhardt K, et al. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. J Control Rel 2004;96:483-95
  • Kreuter J, Hekmatara T, Dreis S, et al. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. J Control Release 2007;118:54-8
  • Michaelis K, Hoffmann MM, Dreis S, et al. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006;317:1246-53
  • Steinhauser I, Spankuch B, Strebhardt K, Langer K. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials 2006;27:4975-83
  • Wartlick H, Michaelis K, Balthasar S, et al. Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. J Drug Target 2004;12:461-71
  • Nobs L, Buchegger F, Gurny R, Allemann E. Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjugate Chem 2006;17:139-45
  • Cheng J, Teply BA, Sherifi I, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007;28:869-76
  • Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 2006;103:6315-20
  • Zhang S, Gangal G. ‘Magic bullets’ for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem Soc Rev 2007;36:507-31
  • Gittens SA, Bansal G, Zernicke RF, Uludag H. Designing proteins for bone targeting. Adv Drug Deliv Rev 2005;57:1011-36
  • Hengst V, Oussoren C, Kissel T, Storm G. Bone targeting potential of bisphosphonate-targeted liposomes: preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm 2007;331:224-7
  • Zhang S, Wright JEI, Uludag H, Ozber N. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite. Macromol Biosci 2007;7:656-70
  • Lochmann D, Vogel V, Weyermann J, et al. Physicochemical characterization of protamine-phosphorothioate nanoparticles. J Microencapsul 2004;21:625-41
  • Duclairoir C, Orecchioni A-M, Depraetere P, et al. Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs. Int J Pharm 2003;253:133-44
  • Irache JM, Bergougnoux L, Ezpeleta I, et al. Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method. Int J Pharm 1995;126:103-9
  • Fattal E, Vauthier C, Aynie I, et al. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J Control Release 1998;53:137-43
  • Reddy LH, Sharma RK, Murthy RSR. Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour. J Drug Target 2004;12:443-51
  • Peracchia MT, Fattal E, Desmaele D, et al. Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Rel 1999;60:121-8
  • Lee MK, Lim SJ, Kim CK. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007;28:2137-46
  • Yuan H, Huang LF, Du YZ, et al. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces 2008;61:132-7
  • Jenning V, Schafer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Rel 2000;66:115-26
  • Cheng WP, Gray AI, Tetley L, et al. Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds. Biomacromolecules 2006;7:1509-20
  • Chen J, Tian B, Yin X, et al. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems. J Biotechnol 2007;130:107-13
  • Lemarchand C, Gref R, Lesieur S, et al. Physico-chemical characterization of polysaccharide-coated nanoparticles. J Control Rel 2005;108:97-111
  • Rodrigues JS, Santos-Magalhaes NS, Coelho LCBB, et al. Novel core(polyester)- shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. J Control Rel 2003;92:103-12
  • Trimaille T, Pichot C, Elaissari A, et al. Poly(D,L-lactic acid) nanoparticle preparation and colloidal characterization. Colloid Polym Sci 2003;281:1184-90
  • Gao H, Yang YW, Fan YG, Ma JB. Conjugates of poly(D,L-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(β-cyclodextrin)s and their nanoparticles as protein delivery systems. J Control Rel 2006;112:301-11
  • Gao H, Wang YN, Fan YG, Ma JB. Conjugates of poly(D,L-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system. J Biomed Mater Res Part A 2007;80A:111-22
  • Lu W, Wan J, She Z, Jiang X. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Rel 2007;118:38-53
  • Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 2005;107:428-48
  • Shenoy DB, Amiji MM. Poly(ethylene oxide)-modified poly(e-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005;293:261-70
  • Akagi T, Kaneko T, Kida T, Akashi M. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(γ-glutamic acid). J Biomater Sci Polym Ed 2006;17:875-92
  • Hirsjarvi S, Peltonen L, Hirvonen J. Layer-by-layer polyelectrolyte coating of low molecular weight poly(lactic acid) nanoparticles. Colloids Surf B Biointerfaces 2006;49:93-9
  • Farokhzad OC, Jon S, Khademhosseini A, et al. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 2004;64:7668-72
  • Perez C, Sanchez A, Putnam D, et al. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Rel 2001;75:211-24
  • Kim IS, Lee SK, Park YM, et al. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm 2005;298:255-62
  • Trimaille T, Pichot C, Delair T. Surface functionalization of poly(D,L-lactic acid) nanoparticles with poly(ethylenimine) and plasmid DNA by the layer-by-layer approach. Colloids Surf A Physicochemical Engin Aspects 2003;221:39-48
  • Messai I, Munier S, Taman-Onal Y, et al. Elaboration of poly(ethyleneimine) coated poly(D,L,-lactic acid) particles. Effect of ionic strength on the surface properties and DNA binding capabilities. Colloids Surf B Biointerfaces 2003;32:293-305
  • Lee SH, Zhang Z, Feng SS. Nanoparticles of poly(lactide) – tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials 2007;28:2041-50
  • Zhang Z, Feng SS. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 2006;27:262-70
  • Song CX, Labhasetwar V, Murphy H, et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Rel 1997;43:197-212
  • Cegnar M, Kos J, Kristl J. Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity. Eur J Pharm Sci 2004;22:357-64
  • Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002;233:51-9
  • Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996;13:1838-45
  • Astete CE, Kumar CS, Sabliov CM. Size control of poly(D,L-lactide-co-glycolide) and poly(D,L-lactide-co-glycolide)-magnetite nanoparticles synthesized by emulsion evaporation technique. Colloids Surf A Physicochemical Engin Aspects 2007;299:209-16
  • Lboutounne H, Guillaume YC, Michel L, et al. Study and development of encapsulated forms of 4, 5, 8-trimethylpsoralen for topical drug delivery. Drug Dev Res 2004;61:86-94
  • Sholes PD, Coombes AGA, Illum L, et al. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Rel 1993;25:145-53
  • Dong Y, Feng SS. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004;25:2843-9
  • Zhang L, Hou S, Mao S, et al. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 2004;287:155-62
  • Rahimnejad M, Jahanshahi M, Najafpour GD. Production of biological nanoparticles from bovine serum albumin for drug delivery. African J Biotechnol 2006;5:1918-23
  • Arbos P, Campanero MA, Arangoa MA, Irache JM. Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. J Control Release 2004;96:55-65
  • Michaelis M, Langer K, Arnold S, et al. Pharmacological activity of DTPA linked to protein-based drug carrier systems. Biochem Biophys Res Commun 2004;323:1236-40
  • Brzoska M, Langer K, Coester C, et al. Incorporation of biodegradable nanoparticles into human airway epithelium cells – in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem Biophys Res Commun 2004;318:562-70
  • Langer K, Coester C, Weber C, et al. Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid. Eur J Pharm Biopharm 2000;49:303-7
  • Arnedo A, Espuelas S, Irache JM. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide. Int J Pharm 2002;244:59-72
  • Huang M, Vitharana SN, Peek LJ, et al. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules 2007;8:1607-14
  • Lin YH, Mi FL, Chen CT, et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 2007;8:146-52
  • Prego C, Torres D, Fernandez-Megia E, et al. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J Control Rel 2006;111:299-308
  • Bravo-Osuna I, Millotti G, Vauthier C, Ponchel G. in vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles. Int J Pharm 2007;338:284-90
  • Mi FL, Wu YY, Chiu YL, et al. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 Cells. Biomacromolecules 2007;8:892-8
  • Tan WB, Huang N, Zhang Y. Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications. J Colloid Interface Sci 2007;310:464-70
  • Chen F, Zhang ZR, Huang Y. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Int J Pharm 2007;336:166-73
  • Bodnar M, Hartmann JF, Borbely J. Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles. Biomacromolecules 2006;7:3030-6
  • Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Rel 2006;115:216-25
  • Cetin M, Aktas Y, Vural I, et al. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Deliv 2007;14:525-9
  • Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007;59:24-34
  • Zhu S, Qian F, Zhang Y, et al. Synthesis and characterization of PEG modified N-trimethylaminoethylmethacrylate chitosan nanoparticles. Eur Polym J 2007;43:2244-53
  • Zhao X, Yu SB, Wu FL, et al. Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles. J Control Rel 2006;112:223-8
  • Cafaggi S, Russo E, Stefani R, et al. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Rel 2007;121:110-23
  • Loretz B, Thaler M, Bernkop-Schnurch A. Role of sulfhydryl groups in transfection? A case study with chitosan-NAC nanoparticles. Bioconjugate Chem 2007;18:1028-35
  • Diebold Y, Jarrin M, Saez V, et al. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007;28:1553-64
  • Bravo-Osuna I, Teutonico D, Arpicco S, et al. Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface. Int J Pharm 2007;340:173-81
  • Krauland AH, Alonso MJ. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int J Pharm 2007;340:134-42
  • Grenha A, Grainger CI, Dailey LA, et al. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur J Pharm Sci 2007;31:73-84
  • Prego C, Fabre M, Torres D, Alonso M. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 2006;23:549-56
  • Zheng Y, Wu Y, Yang W, et al. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci 2007;95:181-91
  • Zhang H, Oh M, Allen C, Kumacheva E. Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules 2004;5:2461-8
  • Chen L, Subirade M. Chitosan/β-lactoglobulin core-shell nanoparticles as nutraceutical carriers. Biomaterials 2005;26:6041-53
  • Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 1997;14:1431-6
  • Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005;44:65-73
  • Sajeesh S, Sharma CP. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. J Biomed Mater Res Part B Appl Biomater 2006;76:298-305
  • Park K, Kim JH, Nam YS, et al. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Rel 2007;122:305-14
  • Jintapattanakit A, Junyaprasert VB, Mao S, et al. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 2007;342:240-9
  • Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir 2005;21:8852-7
  • Mo Y, Lim LY. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Rel 2005;108:244-62
  • Tosi G, Costantino L, Rivasi F, et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-123. J Control Rel 2007;122:1-9
  • Costantino L, Gandolfi F, Tosi G, et al. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Rel 2005;108:84-96
  • Zhang N, Chittasupho C, Duangrat C, et al. PLGA Nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjug Chem 2008;19:145-52

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.